Something went wrong with the connection!

Traumatic Brain Injury Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Companies – NeuroTrauma Sciences, SanBio, Pinteon Therapeutics, Vasopharm

 Breaking News
  • No posts were found

Traumatic Brain Injury Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Companies – NeuroTrauma Sciences, SanBio, Pinteon Therapeutics, Vasopharm

July 17
07:25 2023
Traumatic Brain Injury Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Companies - NeuroTrauma Sciences, SanBio, Pinteon Therapeutics, Vasopharm
DelveInsight Business Research LLP
DelveInsight’s “Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Traumatic Brain Injury, historical and forecasted epidemiology as well as the Traumatic Brain Injury market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Traumatic Brain Injury, historical and forecasted epidemiology as well as the Traumatic Brain Injury market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Traumatic Brain Injury Overview

According to the American Association of Neurological Surgeons (2022), Traumatic Brain Injury is a disruption in the normal function of the brain that can be caused by a blow, bump, or jolt to the head, the head suddenly and violently hitting an object or when an object pierces the skull and enters brain tissue. One of the most widely used systems to classify outcomes from head injury is the Glasgow Outcome Scale (GOS). 

The GCS is a 15-point test used to grade a patient’s level of consciousness. A patient may experience headaches, dizziness, irritability similar symptoms, but these gradually improve in most cases. Mild TBI has a score of 13–15. Moderate TBI has a score of 9–12, and severe Traumatic brain injury has a score of 8 and below. According to the CDC, approximately 2.87 million cases of TBI occurred in the US in 2014 with over 837,000 cases occurring amongst children. An estimated 13.5 million individuals live with a disability due to traumatic brain injury in the US alone

 

Traumatic Brain Injury Epidemiology Insights

  • In the United States, children aged 0–4 years, adolescents aged 15–19 years, and older adults aged ≥75 years are the groups most likely to have a TBI-related ED visit or hospitalization (Faul et al., 2010). 

  • According to Galgano et al. (2017), the highest rates of TBI tend to be in a very young age group (0–4 y) as well as in adolescents and young adults (15–24 y). There is another peak in incidence in the elderly (>65 y).

  • According to data from the Overall Analysis Center of Traffic Accidents (Transportation Statistics 2000), TBI accounted for only 9.3% of 1,160,000 traffic accident injuries. However, of the 9,000 deaths in these data, 50.3% of them were in fact due to Traumatic Brain Injury.

Click here to learn more about the Traumatic Brain Injury Market Landscape

The Report Covers the Traumatic Brain Injury Epidemiology Segmented by:

  • Total Traumatic Brain Injury incident cases 

  • Total Traumatic Brain Injury incident cases based on age 

  • Total Traumatic Brain Injury gender-specific cases 

  • Total Traumatic Brain Injury severity specific cases 

 Traumatic Brain Injury Market Outlook 

The Traumatic Brain Injury market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Traumatic Brain Injury market trends by analyzing the impact of current Traumatic Brain Injury therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

This segment gives a thorough detail of the Traumatic Brain Injury market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Traumatic Brain Injury market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Traumatic Brain Injury market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Traumatic Brain Injury Market

  • NeuroTrauma Sciences

  • SanBio

  • Pinteon Therapeutics

  • Vasopharm

  • NeuroVive Pharmaceutical

  • BioVie

And many others 

Traumatic Brain Injury Therapies Covered and Analyzed in the Report

  • Cannabidiol

  • Glutamine

  • Ketamine

And many others 

Learn more about the Key Companies and Emerging Therapies in the Traumatic Brain Injury Market

Table of Contents 

  1.  Key Insights 

  2.  Traumatic Brain Injury Introduction 

  3.  Executive Summary of Traumatic Brain Injury        

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  Traumatic Brain Injury Emerging Therapies

  7.  Traumatic Brain Injury Market Outlook

  8.  Market Access and Reimbursement of Therapies

  9.  Market Drivers 

  10.  Market Barriers 

  11.  Appendix

  12.  Report Methodology

  13.  DelveInsight Capabilities

  14.  Disclaimer

Learn about the detailed offerings of the report @ Traumatic Brain Injury Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Related Articles

Categories